Trials / Completed
CompletedNCT06288529
EFFECT SGLT2 INHIBITORS ON CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY
PROTECTIVE EFFECT OF SGLT2 INHIBITORS ON POST-CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY IN DIABETIC AND CKD PATIENTS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 975 (actual)
- Sponsor
- University of Health Sciences Balikesir Hospital Eduation and Research · Other Government
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
Chronic kidney disease and type 2 diabetes mellitus patients are with in high-risk patients in coronary arterial diseases and increasing number of coronary angiography and coronary interventional procedures have been performed in these population. As well as the risk factors have been identified by many studies preventive measures are lacking. In our study we found that SGLT2 inhibitors are beneficial in terms of reducing contrast media induced acute kidney injury in both diabetic and CKD patients.This is one of the leading studies in the literature pointing that SGLT2 inhibitors may have a potentially beneficial role in reducing or preventing the development of PC-AKI.
Conditions
Timeline
- Start date
- 2023-07-15
- Primary completion
- 2023-12-31
- Completion
- 2024-01-31
- First posted
- 2024-03-01
- Last updated
- 2024-03-01
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06288529. Inclusion in this directory is not an endorsement.